111 – 120 of 156
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Generation and molecular characterization of head and neck squamous cell lines of Fanconi anemia patients
(
- Contribution to journal › Article
-
Mark
A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells.
(
- Contribution to journal › Article
-
Mark
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
(
- Contribution to journal › Article
-
Mark
DNA adducts and lung cancer risk: A prospective study
(
- Contribution to journal › Article
-
Mark
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells
(
- Contribution to journal › Article
- 2004
-
Mark
Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines.
(
- Contribution to journal › Article
-
Mark
Deletion of laminin-8 results in increased tumor neovascularization and metastasis in mice
(
- Contribution to journal › Article
-
Mark
Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts.
(
- Contribution to journal › Article
-
Mark
Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines
(
- Contribution to journal › Article
-
Mark
Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply
(
- Contribution to journal › Letter